# Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials

> **NCT03611101** · — · COMPLETED · sponsor: **Meridian Bioscience, Inc.** · enrollment: 124 (actual)

## Conditions studied

- NASH - Nonalcoholic Steatohepatitis

## Interventions

- **COMBINATION_PRODUCT:** ¹³C-Methacetin Breath Test
- **DRUG:** BMS-986036
- **DEVICE:** BreathID MCS device

## Key facts

- **NCT ID:** NCT03611101
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-04
- **Primary completion:** 2020-08-18
- **Final completion:** 2021-11-10
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2022-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03611101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03611101, "Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03611101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*